Thomas J Jackson1, Richard D Williams1, Jesper Brok1,2, Tanzina Chowdhury1,3, Milind Ronghe4, Mark Powis5, Kathy Pritchard-Jones1, Gordan M Vujanić6,7. 1. University College London Great Ormond Street Institute of Child Health, London, UK. 2. Department of Paediatric Oncology and Haematology, Rigshospitalet, Copenhagen, Denmark. 3. Department of Oncology, Great Ormond Street Hospital NHS Foundation Trust, London, UK. 4. Department of Paediatric Oncology, Royal Hospital for Children, Glasgow, UK. 5. Department of Paediatric Surgery, Leeds Teaching Hospital NHS Trust, Leeds, UK. 6. Department of Cellular Pathology, University Hospital of Wales, Cardiff, UK. 7. Department of Pathology, Sidra Medicine, Doha, Qatar.
Abstract
INTRODUCTION: The International Society of Paediatric Oncology (SIOP) protocols recommend preoperative chemotherapy appropriate for Wilms tumors (WTs) in children with renal tumors aged ≥6 months, reserving biopsy for "atypical" cases. The Children's Cancer and Leukaemia Group (CCLG) joined the SIOP-WT-2001 study but continued the national practice of biopsy at presentation. METHOD: Retrospective study of concordance between locally reported renal tumor biopsies and central pathology review nephrectomy diagnoses of children enrolled by CCLG centers in the SIOP-WT-2001 study. RESULTS: Biopsy reports were available for 552/787 children with unilateral tumors. 36 of 552 (6.5%) were nondiagnostic: 2 normal tissue, 12 necrotic, 9 insufficient sample, and 13 indeterminate results (disproportionately non-WTs). The sensitivity and specificity of biopsy to identify tumors that did not require SIOP empirical preoperative chemotherapy were 86.0% and 99.6%, respectively. 13 of 548 (2.4%) biopsy results were discordant with nephrectomy; non-WTs other than renal cell carcinoma and clear cell sarcoma of the kidney (CCSK) were poorly recognized. In children aged 6-119 months, 480 of 518 (91.6%) had WT or nephroblastomatosis. 5 of 518 (1%) had benign tumors, and only one diagnosed on biopsy. Biopsy results correctly changed clinical management in 25 of 518 (4.8%), including identifying 19 of 20 CCSKs, but would have led to overtreatment in 5 of 518 (1%) or undertreatment in 4 of 518 (0.8%). In children aged ≥10 years, biopsy correctly changed management in 5 of 19 (26%) cases with no discordance. CONCLUSION: Biopsy is less effective at identifying non-WTs than WTs and rarely changes management in younger children. Biopsy should be reserved in SIOP protocols for children ≥10 years and in younger children with clinical or radiological features inconsistent with WT.
INTRODUCTION: The International Society of Paediatric Oncology (SIOP) protocols recommend preoperative chemotherapy appropriate for Wilms tumors (WTs) in children with renal tumors aged ≥6 months, reserving biopsy for "atypical" cases. The Children's Cancer and Leukaemia Group (CCLG) joined the SIOP-WT-2001 study but continued the national practice of biopsy at presentation. METHOD: Retrospective study of concordance between locally reported renal tumor biopsies and central pathology review nephrectomy diagnoses of children enrolled by CCLG centers in the SIOP-WT-2001 study. RESULTS: Biopsy reports were available for 552/787 children with unilateral tumors. 36 of 552 (6.5%) were nondiagnostic: 2 normal tissue, 12 necrotic, 9 insufficient sample, and 13 indeterminate results (disproportionately non-WTs). The sensitivity and specificity of biopsy to identify tumors that did not require SIOP empirical preoperative chemotherapy were 86.0% and 99.6%, respectively. 13 of 548 (2.4%) biopsy results were discordant with nephrectomy; non-WTs other than renal cell carcinoma and clear cell sarcoma of the kidney (CCSK) were poorly recognized. In children aged 6-119 months, 480 of 518 (91.6%) had WT or nephroblastomatosis. 5 of 518 (1%) had benign tumors, and only one diagnosed on biopsy. Biopsy results correctly changed clinical management in 25 of 518 (4.8%), including identifying 19 of 20 CCSKs, but would have led to overtreatment in 5 of 518 (1%) or undertreatment in 4 of 518 (0.8%). In children aged ≥10 years, biopsy correctly changed management in 5 of 19 (26%) cases with no discordance. CONCLUSION: Biopsy is less effective at identifying non-WTs than WTs and rarely changes management in younger children. Biopsy should be reserved in SIOP protocols for children ≥10 years and in younger children with clinical or radiological features inconsistent with WT.
Authors: R Furtwängler; S L Gooskens; H van Tinteren; J de Kraker; G Schleiermacher; C Bergeron; B de Camargo; T Acha; J Godzinski; B Sandstedt; I Leuschner; G M Vujanic; R Pieters; N Graf; M M van den Heuvel-Eibrink Journal: Eur J Cancer Date: 2013-07-20 Impact factor: 9.162
Authors: Marry M van den Heuvel-Eibrink; Harm van Tinteren; Harriet Rehorst; Aurore Coulombe; Catharine Patte; Beatriz de Camargo; Jan de Kraker; Ivo Leuschner; Rieneke Lugtenberg; Kathy Pritchard-Jones; Bengt Sandstedt; Filippo Spreafico; Norbert Graf; Gordan M Vujanic Journal: Pediatr Blood Cancer Date: 2010-12-22 Impact factor: 3.167
Authors: Lorenzo Marconi; Saeed Dabestani; Thomas B Lam; Fabian Hofmann; Fiona Stewart; John Norrie; Axel Bex; Karim Bensalah; Steven E Canfield; Milan Hora; Markus A Kuczyk; Axel S Merseburger; Peter F A Mulders; Thomas Powles; Michael Staehler; Borje Ljungberg; Alessandro Volpe Journal: Eur Urol Date: 2015-08-29 Impact factor: 20.096
Authors: Simone de Campos Vieira Abib; Chan Hon Chui; Sharon Cox; Abdelhafeez H Abdelhafeez; Israel Fernandez-Pineda; Ahmed Elgendy; Jonathan Karpelowsky; Pablo Lobos; Marc Wijnen; Jörg Fuchs; Andrea Hayes; Justin T Gerstle Journal: Ecancermedicalscience Date: 2022-02-17
Authors: Kayo Nakata; Murielle Colombet; Charles A Stiller; Kathy Pritchard-Jones; Eva Steliarova-Foucher Journal: Int J Cancer Date: 2020-07-22 Impact factor: 7.316